Loading clinical trials...
Loading clinical trials...
A Prospective Single-blind Comparative Clinical Study of Efficacy and Safety of Amizon 0.25 g Tablets, Manufactured by Farmak JSC, in Patients With ARVI, Including Influenza.
Conditions
Interventions
Enisamium Iodide
Placebo
Start Date
April 13, 2009
Primary Completion Date
January 15, 2010
Completion Date
January 15, 2010
Last Updated
January 8, 2026
NCT04431050
NCT02387294
NCT03448705
NCT02072174
NCT03572491
NCT01651104
Lead Sponsor
Joint Stock Company "Farmak"
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions